This regulation may be cited as the Medicines and Poisons (Medicines) Amendment Regulation (No. 3) 2025.
This regulation amends the Medicines and Poisons (Medicines) Regulation 2021.
3Amendment of sch 2 (Categories of medicines)
Schedule 2, part 1, division 1, entries for buprenorphine for treating opioid dependency and methadone for treating opioid dependency, ‘dependency’—
omit, insert—dependence
4Amendment of sch 6 (Medical practitioners and assistants)
(1)Schedule 6, section 5, heading, ‘Definition’—
omit, insert—Definitions
(2)Schedule 6, section 5—
insert—continuing opioid dependence treatment, by a medical practitioner of a patient, means—(a)the practitioner is treating the patient with an approved opioid in a hospital or custodial facility; and(b)the patient was being treated with the approved opioid under an opioid treatment program within a reasonable period before—(i)being admitted to the hospital or being taken into custody at the custodial facility; or(ii)being treated by the practitioner.(3)Schedule 6, section 5, definition continuing institutional treatment, paragraphs (a) and (b)—
omit, insert—(a)the practitioner is treating the patient in a hospital or custodial facility; and(b)the patient was being treated with the medicine within a reasonable period before—(i)being admitted to the hospital or being taken into custody at the custodial facility; or(ii)being treated by the practitioner.(4)Schedule 6, section 7, table—
omit, insert—
Column 1
Dealing
Column 2
Medicine
Column 3
Scope of dealing
1
prescribe
the medicine is prescribed for administration by a health practitioner—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to prescribe the medicinethe medicine is prescribed for administration by a health practitioner for the continuing opioid dependence treatment of a patient
2
administer
the medicine is administered—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to administer the medicinethe medicine is administered for the continuing opioid dependence treatment of a patient
3
possess
the medicine is possessed—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to possess the medicinethe medicine is possessed for the continuing opioid dependence treatment of a patient
5Amendment of sch 7 (Nursing and midwifery professions)
(1)Schedule 7, section 1—
insert—continuing opioid dependence treatment, by a nurse practitioner of a patient, means—(a)the practitioner is treating the patient with an approved opioid in a hospital or custodial facility; and(b)the patient was being treated with the approved opioid under an opioid treatment program within a reasonable period before—(i)being admitted to the hospital or being taken into custody at the custodial facility; or(ii)being treated by the practitioner.(2)Schedule 7, section 1, definition continuing institutional treatment, paragraphs (a) to (c)—
omit, insert—(a)the practitioner is treating the patient in a hospital or custodial facility; and(b)the patient was being treated with the medicine within a reasonable period before—(i)being admitted to the hospital or being taken into custody at the custodial facility; or(ii)being treated by the practitioner.(3)Schedule 7, section 3, table, entry for item 1—
omit, insert—
1
prescribe
the medicine is prescribed for administration by a health practitioner—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to prescribe the medicinethe medicine is prescribed for the continuing hydroxychloroquine treatment of a patient
the medicine is prescribed for administration for the continuing opioid dependence treatment of a patient
(4)Schedule 7, section 3, table, entries for items 3 and 4—
omit, insert—
3
give a treatment dose
the medicine is given—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to give the medicinethe medicine is given for the continuing hydroxychloroquine treatment of a patient
4
administer
the medicine is administered—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to administer the medicinethe medicine is administered for the continuing hydroxychloroquine treatment of a patient
the medicine is administered for the continuing opioid dependence treatment of a patient
the medicine is administered on a prescription
6Amendment of sch 12 (Other health practitioners)
(1)Schedule 12, section 6, table, entry for item 1—
omit, insert—
1
administer
the medicine is administered—
the nuclear medicine technologist has completed anaphylaxis training and the medicine is administered to treat anaphylaxis—
omit, insert—or S8 medicine
(3)Schedule 12, section 6, table—
insert—
3
dispose
waste from a diversion-risk medicine mentioned in this column
7Amendment of sch 14 (Suppliers and representatives)
(1)Schedule 14, section 4, table, column 3, paragraph (b), ‘a’—
omit.(2)Schedule 14, section 6, table, column 3, paragraph (b), ‘a person’—
omit, insert—someone